CONCLUSION
ESUS patients were older and had a higher prevalence of diabetes and
hypertension, while active smoking was more common among migraine
patients. Echocardiographic assessments showed no significant
differences in heart dimensions or valvular issues. However, ESUS
patients had higher pulmonary artery systolic pressure (PASP). ESUS
patients showed more microbubble crossings through the interatrial
septum (IAS) and longer PFOs. While the RoPe score was similar, the
High-risk PFO score was slightly higher in ESUS patients. This study
highlights differences between migraine and ESUS patients in terms of
some demographic, comorbid, and echocardiographic parameters.
- Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen
ovale during the first 10 decades of life: an autopsy study of 965
normal hearts. Mayo Clin Proc 1984;59:17–20.
- Andrews R, Tulloh R, Magee A, et al. Atrial septal defect with failure
to thrive in infancy: hidden pulmonary vascular disease. Pediatr
Cardiol 2002;23:528-30.
- Lammers A, Hager A, Eicken A, et al. Need for closure of secundum
atrial septal defect in infancy. J Thorac Cardiovasc Surg
2005;129:1353-57.
- Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen
ovale in patients with stroke. N Engl J Med 1988;318:1148–52.
- Liu K, Wang BZ, Hao Y, et al. The Correlation Between Migraine and
Patent Foramen Ovale. Frontiers in Neurology 2020;11.
- Naqvi N, McCarthy KP, Ho SY. Anatomy of the atrial septum and
interatrial communications. Journal of Thoracic Disease 2018;10(Suppl
24), S2837.
- Hibi N, Kambe T, Itoh K, et al. Cross-sectional echocardiographic
study on atrial septal defect: pre- and postoperative considerations.
Japanese heart journal 1986;23(2), 147–159.
- Rozensweig BP, Nayar AC, Varkey MP, et al. Echo contrast enhanced
diagnosis of atrial septal defect. J Am Soc Echocardiogr
2001;14:155-57.
- Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events
associated with patent foramen ovale, atrial septal aneurysm, or both.
N Engl J Med 2001;345:1740–6.
- Falanga, G., Carerj, S., Oreto, G., Khandheria, B. K., & Zito, C.
(2014). How to Understand Patent Foramen Ovale Clinical Significance:
Part I. Journal of cardiovascular echography , 24 (4),
114–121.
- Lucà, F., Pino, P. G., Parrini, I., Di Fusco, S. A., Ceravolo, R.,
Madeo, A., Leone, A., La Mair, M., Benedetto, F. A., Riccio, C.,
Oliva, F., Colivicchi, F., Gulizia, M. M., & Gelsomino, S. (2023).
Patent Foramen Ovale and Cryptogenic Stroke: Integrated
Management. Journal of clinical medicine , 12 (5), 1952.
- Nakayama R, Takaya Y, Akagi T, Watanabe N, Ikeda M, Nakagawa K, Toh N,
Ito H.. Identification of high risk patent foramen ovale associated
with cryptogenic stroke: development of a scoring system. J Am
Soc Echocardiogr 2019;32:811–816.
- Radico, F., Foglietta, M., Di Fulvio, M., Appignani, M., Rossi, S.,
Angelis, M. V., Gallina, S., & Zimarino, M. (2021). The ’dreaded
PFO’: anatomical and functional features of high risk for
stroke. European heart journal supplements : journal of the
European Society of Cardiology , 23 (Suppl E), E189–E193.
- Kent DM, Ruthazer R, Weimar C, Mas J-L, Serena J, S, Di Angelantonio
E, Di Tullio MR, Lutz JS, Elkind MSV, Griffith J, Jaigobin C, Mattle
HP, Michel P, Mono M-L, Nedeltchev K, Papetti F, Thaler DE.. An index
to identify stroke-related vs incidental patent foramen ovale in
cryptogenic stroke. Neurology 2013;81:619–625.
- Van der Giessen, H., Wilson, L. C., Coffey, S., & Whalley, G. A.
(2020). Review: Detection of patient foramen ovale using transcranial
Doppler or standard echocardiography. Australasian journal of
ultrasound in medicine , 23 (4), 210–219.
- Ioannidis, S. G., & Mitsias, P. D. (2020). Patent Foramen Ovale in
Cryptogenic Ischemic Stroke: Direct Cause, Risk Factor, or Incidental
Finding?. Frontiers in neurology , 11 , 567.
- Tobis, M. J., & Azarbal, B. (2005). Does patent foramen ovale promote
cryptogenic stroke and migraine headache?. Texas Heart Institute
journal , 32 (3), 362–365.
- W, Shen Y, Zhong J, et al. The Patent Foramen Ovale and Migraine:
Associated Mechanisms and Perspectives from MRI Evidence. Brain
Sciences 2022; 12(7):941.
- Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent
foramen ovale associated with cryptogenic stroke. A biplane
transesophageal echocardiographic study. Stroke 1994;25:582–6.
- Stone DA, Godard J, Corretti MC, et al. Patent foramen ovale:
association between the degree of shunt by contrast transesophageal
echocardiography and the risk of future ischemic neurologic events. Am
Heart J 1996;131:158–61.
- Fuse S, Tomita H, Hatakeyama K, et al. Effect of a secundum atrial
septal defect on shunt volume. Am J Cardiol 2001;88:1447-50.
- Schuchlenz HW, Saurer G, Weihs W, et al. Persisting eustachian valve
in adults: relation to patent foramen ovale and cerebrovascular
events. J Am Soc Echocardiogr 2004;17:231–3.
- Gin KG, Huckell VF, Pollick C. Femoral vein delivery of contrast
medium enhances transthoracic echocardiographic detection of patent
foramen ovale. J Am Coll Cardiol 1993;22:1994–2000.
Table 1 Baseline clinical and echocardiographic characteristics
of the study population
Table 2 Comparison of basal characteristics and
echocardiographic features by study groups
Figure 1 Comparison of PFO height and PFO length measurements
in migraine and ESUS patients with Box Plot graph
Figure 2 Comparison of RoPe score and anatomical and functional
high-risk PFO score in migraine and ESUS patients with Box Plot graph